Study of BMF-219 in Healthy Adult Subjects and in Adult Subjects With Type 2 Diabetes Mellitus (T2D)

NCT05731544 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

443

Enrollment

INDUSTRY

Sponsor class

Conditions

Type 2 Diabetes Mellitus

Interventions

DRUG: BMF-219

Sponsor

Biomea Fusion Inc.